Background/Aims: The General Practitioner Assessment of Cognition (GPCOG) is a brief cognitive test. This study compared the GPCOG to the Mini-Mental State Examination (MMSE), the most widely used test, in terms of their ability to detect likely dementia in primary care. Methods: General practitioners across three states in Australia recruited 2,028 elderly patients from the community. A research nurse administered the GPCOG and the MMSE, as well as the Cambridge Examination for Mental Disorders of the Elderly Cognitive Scale-Revised that we used to define likely dementia. Results: Overall, the GPCOG and the MMSE were similarly effective at detecting likely dementia. The GPCOG, however, had a higher sensitivity than the MMSE when using published cutpoints. Conclusion: The GPCOG is an effective screening tool for dementia in primary care. It appears to be a viable alternative to the MMSE, whilst also requiring less time to administer.

Keywords:
Alzheimer’s disease, Assessment, Cognitive test, Dementia, General practice, General Practitioner Assessment of Cognition, Mini-Mental State Examination, Primary care
1.
Brodaty H, Connors M, Pond D, Cumming A, Creasey H: Dementia: 14 essentials of assessment and care planning. Med Today 2013;14:18-27.
2.
Brodaty H, Connors M, Pond D, Cumming A, Creasey H: Dementia: 14 essentials of management. Med Today 2013;14:29-41.
3.
Pond CD, Mate KE, Phillips J, Stocks NP, Magin PJ, Weaver N, Brodaty H: Predictors of agreement between general practitioner detection of dementia and the revised Cambridge Cognitive Assessment (CAMCOG-R). Int Psychogeriatr 2013;25:1639-1647.
4.
Bradford A, Kunik ME, Schulz P, Williams SP, Singh H: Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord 2009;23:306-314.
5.
Löppönen M, Räihä I, Isoaho R, Vahlberg T, Kivelä SL: Diagnosing cognitive impairment and dementia in primary health care - a more active approach is needed. Age Ageing 2003;32:606-612.
6.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
7.
Hobbs FDR, Bankhead C, Mukhtar T, Stevens S, Perera-Salazar R, Holt T, Salisbury C: Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007-14. Lancet 2016;387:2323-2330.
8.
Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA: The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 2002;50:530-534.
9.
Brodaty H, Kemp NM, Low LF: Characteristics of the GPCOG, a screening tool for cognitive impairment. Int J Geriatr Psychiatry 2004;19:870-874.
10.
Thomas P, Hazif-Thomas C, Viéban F, Faugeron P, Peix R, Clément JP: The GPcog for detecting a population with a high risk of dementia (in French). Psychol Neuropsychiatr Vieil 2006;4:69-77.
11.
Pirani A, Brodaty H, Martini E, Zaccherini D, Neviani F, Neri M: The validation of the Italian version of the GPCOG (GPCOG-It): a contribution to cross-national implementation of a screening test for dementia in general practice. Int Psychogeriatr 2010;22:82-90.
12.
Li X, Xiao S, Fang Y, Zhu M, Wang T, Seeher K, Brodaty H: Validation of the General Practitioner Assessment of Cognition - Chinese version (GPCOG-C) in China. Int Psychogeriatr 2013;25:1649-1657.
13.
Milne A, Culverwell A, Guss R, Tuppen J, Whelton R: Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr 2008;20:911-926.
14.
Ismail Z, Rajji TK, Shulman KI: Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 2010;25:111-120.
15.
Brodaty H, Low LF, Gibson L, Burns K: What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry 2006;15:391-400.
16.
Roth M, Huppert FA, Mountjoy CQ, Tym E: CAMDEX-R. The Revised Cambridge Examination for Mental Disorders of the Elderly-Revised. Cambridge, Cambridge University Press, 1999.
17.
Pond CD, Brodaty H, Stocks NP, Gunn J, Marley J, Disler P, Magin P, Paterson N, Horton G, Goode S, Paine B, Mate KE: Ageing in general practice (AGP) trial: a cluster randomised trial to examine the effectiveness of peer education on GP diagnostic assessment and management of dementia. BMC Fam Pract 2012;13:12.
18.
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37-49.
19.
DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
20.
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M: pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
21.
Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, Thom VM, Nash KJE, Elhamoui H, Milligan R, Patel AS, Tsivos DV, Wing T, Phillips E, Kellman SM, Shackleton HL, Singleton GF, Neale BE, Watton ME, Cullum S: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev 2016;1:CD011145.
22.
Ebell MH: Brief screening instruments for dementia in primary care. Am Fam Physician 2009;79:497-500.
23.
Australian Institute of Health and Welfare: Dementia in Australia (Cat. no. AGE 70). Canberra, AIHW, 2012.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.